Simon Pedder
CIK 1316736 · Executive Chairman · last filed 2025-09-10
Simon Pedder is an Executive Chairman who has filed 37 SEC Form 4 insider transactions across 7 companies since 2007. Across all open-market trades the lifetime net is +$165.1K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
7
37
$165.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Athenex, Inc. (ATNX) Delisted | See Remarks | 5,310 | $0.20 | $1.1K | $40.8K | 9 | 2021-08-05 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Executive Chairman of the Bd | 241,833 | $2.93 | $708.6K | $50.4K | 8 | 2020-04-13 |
| DCTH | Director | — | $11.72 | — | $0 | 1 | 2019-02-05 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | — | — | — | $0 | 4 | 2018-10-01 |
| Oncotelic Therapeutics, Inc. (OXGN) Delisted | Director | — | — | — | $0 | 2 | 2016-06-03 |
| Cellectar Biosciences, Inc. (CLRB.W) Delisted | President and CEO | 13,300 | — | — | $49.9K | 1 | 2014-08-22 |
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Chief Executive Officer | 488,180 | — | — | $23.9K | 9 | 2012-01-27 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-10 | — | Grant (A) | — | $0 | |
| 2021-08-05 | Athenex, Inc. (ATNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-06 | Athenex, Inc. (ATNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-13 | Avalo Therapeutics, Inc. (CERC) Delisted | Tax (F) | −20,901 | -$53.7K | EDGAR |
| 2019-08-29 | Avalo Therapeutics, Inc. (CERC) Delisted | Buy (P) | +6,734 | $20.1K | EDGAR |
| 2019-07-02 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-29 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | +250,000 | $0 | EDGAR |
| 2019-05-16 | Avalo Therapeutics, Inc. (CERC) Delisted | Buy (P) | +6,000 | $30.3K | EDGAR |
| 2019-04-17 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-17 | Athenex, Inc. (ATNX) Delisted | Grant (A) | +1,402 | $0 | EDGAR |